{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:33:15Z","timestamp":1792762395507,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.drugalcdep.2013.05.010","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T19:54:44Z","timestamp":1370375684000},"page":"188-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial"],"prefix":"10.1016","volume":"133","author":[{"given":"Michelle R.","family":"Lofwall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanna","family":"Babalonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0005","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA), 2011. Results from the 2010 National Survey on Drug Use and Health (NSDUH): Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2012.09.018","article-title":"Abuse liability and reinforcing efficacy of oral tramadol in humans","volume":"129","author":"Babalonis","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2005.11.054","article-title":"Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis","volume":"531","author":"Barann","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/ajem.2003.50039","article-title":"Withdrawal syndrome from tramadol hydrochloride","volume":"21","author":"Barsotti","year":"2003","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0025","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D","article-title":"Internal consistencies of the original and revised Beck Depression Inventory","volume":"40","author":"Beck","year":"1984","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/js950403a","article-title":"Differential effects of food on the bioavailability of controlled-release oxycodone tablets and immediate-release oxycodone solution","volume":"85","author":"Benziger","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0885-3924(96)00300-4","article-title":"A pharmacokinetic\/pharmacodynamic study of controlled-release oxycodone","volume":"13","author":"Benziger","year":"1997","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2003.10.012","article-title":"Prescription opioid abuse in patients presenting for methadone maintenance treatment","volume":"73","author":"Brands","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0376-8716(99)00041-1","article-title":"A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States","volume":"57","author":"Cicero","year":"1999","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pds.1113","article-title":"Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994\u20132004","volume":"14","author":"Cicero","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc. Series B Stat. Methodol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1192\/bjp.128.3.280","article-title":"The SCL-90 and the MMPI: a step in the validation of a new self-report scale","volume":"128","author":"Derogatis","year":"1976","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2125.1996.tb00152.x","article-title":"Contribution of monoaminergic modulation to the analgesic effect of tramadol","volume":"41","author":"Desmeules","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0075","first-page":"449","article-title":"Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans","volume":"276","author":"Eissenberg","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1213\/01.ane.0000189613.61910.32","article-title":"The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6","volume":"102","author":"Enggaard","year":"2006","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biopsycho.2006.01.010","article-title":"Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol","volume":"73","author":"Epstein","year":"2006","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00228-005-0920-y","article-title":"The effects of tramadol on static and dynamic pupillometry in healthy subjects \u2013 the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status","volume":"61","author":"Fliegert","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/eujp.2000.0187","article-title":"Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study","volume":"4","author":"Freye","year":"2000","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s002100000266","article-title":"Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor","volume":"362","author":"Gillen","year":"2000","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a Short Opiate Withdrawal Scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0110","series-title":"Goodman and Gillman's The Pharmacologic Basis of Therapeutics","article-title":"Chapter 21 opioid analgesics","author":"Gutstein","year":"2006"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0115","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2165\/00003495-200666150-00014","article-title":"Tramadol extended-release tablets","volume":"66","author":"Hair","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0125","unstructured":"IMS Health, 2012. National Prescription AuditTM, Top 25 Pharmaceutical Products by Dispensed Prescriptions in the US Market. http:\/\/www.imshealth.com"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0130","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0135","first-page":"877","article-title":"Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids","volume":"38","author":"Hennies","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1037\/0022-006X.60.5.689","article-title":"Tobacco withdrawal in self-quitters","volume":"60","author":"Hughes","year":"1992","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1300\/J069v25n02_08","article-title":"The diversion of ultram, ultracet, and generic tramadol HCL","volume":"25","author":"Inciardi","year":"2006","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0150","first-page":"103","article-title":"Abuse potential of oral tramadol","volume":"132","author":"Jasinski","year":"1993","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0014-2999(96)00770-4","article-title":"Tramadol M1 metabolite and enantiomer affinities for cloned human opioid receptors expressed in transfected HN9.10 neuroblastoma cells","volume":"316","author":"Lai","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-010-1919-3","article-title":"Physical dependence potential of daily tramadol dosing in humans","volume":"211","author":"Lanier","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0740-5472(00)00098-2","article-title":"Methadone detoxification of tramadol dependence","volume":"19","author":"Leo","year":"2000","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0170","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-007-0847-3","article-title":"Modest opioid withdrawal suppression efficacy of oral tramadol in humans","volume":"194","author":"Lofwall","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0175","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/0091270011401620","article-title":"Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers","volume":"52","author":"Lofwall","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0180","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the Addiction Severity Index. Reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","article-title":"An automated version of the digit symbol substitution test (DSST)","volume":"14","author":"McLeod","year":"1982","journal-title":"Behav. Res. Methods Instrum."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill Pain Questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2013.05.010_bib0200","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/(SICI)1099-1557(199904)8:1+<S63::AID-PDS399>3.3.CO;2-D","article-title":"Bladder dysfunction during the use of tramadol","volume":"8","author":"Meyboom","year":"1999","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0205","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/ADM.0b013e318277e92e","article-title":"A comparison of buprenorphine taper outcomes between prescription opioid and heroin users","volume":"7","author":"Nielsen","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0215","unstructured":"Ortho-McNeil, I., 2006. Ultram ER (Tramadol HCl Extended Release Tablets) Package Insert LB0047-01."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0220","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2125.1992.tb04090.x","article-title":"The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects","volume":"33","author":"Poyhia","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0376-8716(91)90081-9","article-title":"Abuse potential and pharmacological comparison of tramadol and morphine","volume":"27","author":"Preston","year":"1991","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)11227-5","article-title":"Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an \u2018atypical\u2019 opioid analgesic","volume":"260","author":"Raffa","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-3565(25)39454-1","article-title":"Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol","volume":"267","author":"Raffa","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0240","first-page":"406","article-title":"Withdrawal syndrome after long-term treatment with tramadol","volume":"50","author":"Rodriguez Villamanan","year":"2000","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0245","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.289.18.2370","article-title":"Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities","volume":"289","author":"Rosenblum","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0250","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2007.02.012","article-title":"Prescription opioid abuse among enrollees into methadone maintenance treatment","volume":"90","author":"Rosenblum","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0255","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10550490600625624","article-title":"Characterizing the emerging population of prescription opioid abusers","volume":"15","author":"Sigmon","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0260","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1360-0443.2004.00834.x","article-title":"Evaluation of an injection depot formulation of buprenorphine: placebo comparison","volume":"99","author":"Sigmon","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0265","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0376-8716(97)00099-9","article-title":"Drug abuse treatment retention and process effects on follow-up outcomes","volume":"47","author":"Simpson","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v22n04_03","article-title":"The use of tramadol for acute heroin withdrawal: a comparison to clonidine","volume":"22","author":"Sobey","year":"2003","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0275","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archpsyc.1992.01820080032005","article-title":"The Structured Clinical Interview for DSM-III-R (SCID) I: history, rationale, and description","volume":"49","author":"Spitzer","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0280","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-010-1942-4","article-title":"Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies","volume":"212","author":"Stoops","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0285","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00213-012-2739-4","article-title":"Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment","volume":"223","author":"Stoops","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0290","first-page":"628","article-title":"Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone","volume":"272","author":"Strain","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v22n04_02","article-title":"Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study","volume":"22","author":"Tamaskar","year":"2003","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0300","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1360-0443.1991.tb01732.x","article-title":"The development and initial validation of a questionnaire on smoking urges","volume":"86","author":"Tiffany","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0305","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/pds.1838","article-title":"Tramadol dependence: a survey of spontaneously reported cases in Sweden","volume":"18","author":"Tjaderborn","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0310","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.drugalcdep.2007.01.011","article-title":"Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary study","volume":"89","author":"Toll","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0315","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0320","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0376-8716(03)00198-4","article-title":"An independent assessment of MEDWatch reporting for abuse\/dependence and withdrawal from Ultram (tramadol hydrochloride)","volume":"72","author":"Woody","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0325","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.drugalcdep.2005.05.007","article-title":"Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users","volume":"80","author":"Zacny","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.05.010_bib0330","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/10550887.2012.665728","article-title":"Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial","volume":"31","author":"Zarghami","year":"2012","journal-title":"J. Addict. Dis."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613001853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613001853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T11:50:44Z","timestamp":1746013844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871613001853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0376871613001853"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.05.010","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}